[Pneumococcal infections in intensive care. Retrospective 8 year study]

Presse Med. 1999 Sep 25;28(28):1505-8.
[Article in French]

Abstract

Objective: The aim of this study was to analyze the clinical presentations and severity of S. pneumoniae infections requiring hospitalization in an intensive care unit and evaluate the incidence and severity of infections caused by penicillin-resistant strains.

Patients and methods: This retrospective study reviewed cases in our intensive care unit from January 1989 through December 1996 including all patients with pneumococcal infection.

Results: The study included 102 patients, mean age 59.6 years. Pneumonia was the most frequent (83 cases) followed by bacteriemia (31 cases) and meningitis (15 cases). Mortality was high (43%) and influenced by age, simplified severity score, and presence of shock at admission. Antibiotic resistance appeared in 1991 and increased over the years reaching, in 1996: 24% for penicillin, 38% for macrolides, 20% for sulfamides, 19% for tetracyclins, and 14% for phenicols. Penicillin-resistance was not found to modify clinical expression nor severity of infection. Amoxicillin and third-generation cephalosporins were the most widely used antibiotics.

Conclusion: Pneumococcal infections in intensive care patients are severe with high mortality. The emergence of more and more resistant strains has little clinical consequence on severity or treatment.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • France / epidemiology
  • Hospital Mortality
  • Hospitalization / statistics & numerical data*
  • Hospitalization / trends*
  • Humans
  • Incidence
  • Intensive Care Units*
  • Length of Stay / statistics & numerical data
  • Middle Aged
  • Penicillin Resistance
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology*
  • Pneumococcal Infections / therapy
  • Population Surveillance
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index

Substances

  • Anti-Bacterial Agents